Small unilamellar neutral, negatively and positively charged liposomes composed of egg phosphatidylcholine, various amounts of cholesterol and, when appropriate, phosphatidic acid or stearylamine and containing 6-carboxyfluorescein were injected into mice, incubated with mouse whole blood, plasma or serum or stored at 4°C. Liposomal stability, i.e. the extent to which 6-carboxyfluorescein is retained by liposomes, was dependent on their cholesterol content.
Small unilamellar neutral, negatively and positively charged liposomes composed of egg phosphatidylcholine, various amounts of cholesterol and, when appropriate, phosphatidic acid or stearylamine and containing 6-carboxyfluorescein were injected into mice, incubated with mouse whole blood, plasma or serum or stored at 4°C. Liposomal stability, i.e. the extent to which 6-carboxyfluorescein is retained by liposomes, was dependent on their cholesterol content.
(1) Cholesterol-rich (egg phosphatidylcholine/ cholesterol, 7: 7 molar ratio) liposomes, regardless of surface charge, remained stable in the blood of intravenously injected animals for up to at least 400 min. In addition, stability of cholesterol-rich liposomes was largely maintained in vitro in the presence of whole blood, plasma or serum for at least 90 min. (2) Cholesterol-poor (egg phosphatidylcholine/cholesterol, 7 :2 molar ratio) or cholesterol-free (egg phosphatidylcholine) liposomes lost very rapidly (at most within 2 min) much of their stability after intravenous injection or upon contact with whole blood, plasma or serum. Whole blood and to some extent plasma were less detrimental to stability than was serum. (3) After intraperitoneal injection, neutral cholesterol-rich liposomes survived in the peritoneal cavity to enter the blood circulation in their intact form. Liposomes injected intramuscularly also entered the circulation, although with somewhat diminished stability. (4) Stability of neutral and negatively charged cholesterol-rich liposomes stored at 4°C was maintained for several days, and by 53 days it had declined only moderately. Stored liposomes retained their unilamellar structure and their ability to remain stable in the blood after intravenous injection. (5) Control of liposomal stability by adjusting their cholesterol content may help in the design of liposomes for effective use in biological systems in vivo and in vitro.
An important prerequisite for the effective use of liposomes as a drug carrier is control over their stability . Defined here as the extent to which the carrier retains its drug contents in vitro or in vivo, stability is influenced not only by the biological environment with which liposomes come into contact, but also by their structural characteristics as well as those of the associated drugs Kimelberg & Mayhew, 1978) . For instance, liposomes containing charged lipids retain certain drugs through electrostatic bonding (Gregoriadis et al., 1977) , and lipophilic drugs (Gregoriadis, 1973; Juliano & Stamp, 1978; Dingle et al., 1978) can be anchored into the liposomal lipid phase. On the other hand, entrapped macromolecules, such as enzymes (Gregoriadis & Ryman, 1972; Weissmann et al., 1975) , nucleic acids (Dimitriadis, 1978; Ostro et al., 1978) , polymers (Dapergolas et al., 1976) and viruses (Wilson et al., 1977) Vol. 186 or viral components (Manesis et al., 1979) , are unable to cross the lipid bilayer because of their large size.
One variant in the liposomal structure that could control retention of drugs is cholesterol content. Indeed, numerous studies on the use of liposomes as membrane models have shown that cholesterol, by increasing the packing of phospholipid molecules (Ladbrooke et al., 1968; Demel & de Kruyff, 1976) , reduces bilayer permeability to non-electrolyte and electrolyte solutes (de Gier et al., 1970; Demel et al., 1972; Papahadjopoulos et al., 1973) . To our knowledge, there has been no investigation into a possible role for the sterol in improving retention of solutes by liposomes within a biological milieu. In the present report we have therefore studied in vivo and in vitro the effect of the cholesterol content of unilamellar liposomes composed of egg phosphatidylcholine on their stability. This was monitored by measuring changes in membrane permeability to 6-carboxyfluorescein entrapped at a concentration that, because of self-quenching, prohibits its fluorescence (Weinstein et al., 1977) . When, for any reason, liposomes become leaky to the dye, its escape and ensuing dilution in the surrounding medium enable it to fluoresce, thus providing an immediate and easily measurable index of membrane permeability (Weinstein et al., 1977; Wreschner & Gregoriadis, 1978; Gregoriadis & Davis, 1979) . Our results show that a high content of cholesterol in such liposomes is essential for the maintenance of their stability under a variety of experimental conditions. Stability is also promoted by the presence of blood cells and, to some extent, plasma.
Materials and Methods
The sources and grades of egg phosphatidylcholine, cholesterol, phosphatidic acid, stearylamine and 6-carboxyfluorescein have been described elsewhere (Gregoriadis, 1976; Gregoriadis & Davis, 1979 
Experiments in vivo
Liposomal 6-carboxyfluorescein was injected into T.O. mice, weighing 20-25 g, by the intravenous (tail vein, 0.2ml), intraperitoneal (0.5 ml) and intramuscular (hindleg, 0.2 ml) routes. In some experiments, mice were injected intravenously with free 6-carboxyfluorescein in 0.2 ml of phosphate buffer (for details see the Results section). At time intervals, 25-5Ou1 of blood was collected in micro-pipettes and rapidly mixed with 2.0 ml of phosphate buffer in conical glass tubes. Immediately before fluorescence measurements, the tubes were centrifuged at 3000rev./min for 5min and the supernatants analysed for 6-carboxyfluorescein in the absence and presence of Triton X-100 (1% final concentration). Latent 6-carboxyfluorescein in the blood, derived as above from the difference in fluorescence values obtained with and without Triton X-100, was determined as the percentage of the total dye in the sample. Unless otherwise stated, these values were subsequently expressed as percentages of the latency in the liposomal preparation used. It was established that the amount of latent 6-carboxyfluorescein in the diluted blood was not altered upon standing for at least several hours. In experiments with liposomes labelled with [14C]cholesteryl oleate, portions of the supernatants were used for the assay of 14C radioactivity (Gregoriadis et al., 1977) .
Experiments in vitro
Liposomal 6-carboxyfluorescein was incubated at 370C with fresh mouse blood mixed with the anticoagulant sodium citrate (0.63% final concentration), with fresh mouse plasma obtained from such blood or with fresh mouse serum. The volume ratio of biological fluid/liposomes was 10 (whole blood) and 5 (plasma or serum) i.e. similar to that expected upon intravenous injection of mice with 0.2 ml of liposomes (2 ml and 50% assumed blood volume and haematocrit respectively). At time intervals, 25 ,1 samples were obtained and assayed for 6-carboxyfluorescein as for the experiments in vivo. Latent 6-carboxyfluorescein in the blood was again expressed as percentage of that in the preparation used. In control experiments 6-carboxyfluorescein latency was measured in liposomes incubated for 90min in the presence of 1% NaCl containing sodium citrate (0.63% final concentration).
Stability experiments Immediately after their preparation, neutral and negatively charged liposomes labelled with [14C]-cholesteryl oleate and containing 6-carboxyfluorescein were passed through Millipore filters (0.22,um pore diameter), and distributed under sterile conditions into glass vials. These were then flushed with N2, sealed and kept in the dark at 40C. At time intervals, vial contents were analysed for 6-carboxyfluorescein latency and 14C radioactivity. In addition, portions (0.2ml) were injected intravenously into mice as above, and total and latent 6-carboxyfluorescein as well as 14C radioactivity were subsequently measured in blood samples.
Results
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo Intravenous injection of mice with free 6-carboxyfluorescein was followed by a rapid linear clearance of the dye from the circulation with less than 5% remaining in the blood after 60min (Fig. 1) .
There was only a minor reduction in the rate of clearance when 6-carboxyfluorescein was entrapped in cholesterol-free (egg phosphatidylcholine) or cholesterol-poor (egg phosphatidylcholine/cholesterol, 7:2 molar ratio) liposomes (about 6 and 9% of the dose respectively at 60min). With both these preparations, clearance rates were non-linear and consistent with the behaviour expected from solutes that are released from their liposomal carrier in the circulation (Gregoriadis, 1973) . Such release of 6-carboxyfluorescein was reflected in: (a) the very rapid (within 2min) reduction of its latency to 45% (cholesterol-poor liposomes; results not shown) and 30% (cholesterol-free liposomes) of the values in the injected preparations (Fig. 2) [however, with cholesterol-free liposomes latency was subsequently increased to higher values (see the Discussion section)]; (b) the increase in the liposomal lipid "4C/6-carboxyfluorescein ratio from the arbitrary value of 1.0 in the injected preparations to 9.2 (cholesterolpoor) and 14.3 or 18.3 (cholesterol-free liposomes) 150min after injection (Table 1) . In contrast, 6-carboxyfluorescein entrapped in cholesterol-rich (egg phosphatidylcholine/cholesterol, 7:7 molar ratio) liposomes exhibited a slow linear clearance, with about 70% of the dose being present in the blood at 60min, suggesting that the dye was eliminated from the blood in association with its carrier. This was confirmed by findings ( Fig. 2) showing complete (100%) maintenance of 6-carboxyfluorescein latency in these liposomes for at least 400min after injec- Vol. 186
tion. Quantitative retention of 6-carboxyfluorescein by intact cholesterol-rich liposomes was further supported by results in Table 1 : the ratio of the liposomal lipid "4C/6-carboxyfluorescein markers retained its initial value of 1.0 for at least 150min.
At later time intervals radioactivity values were too low for the accurate determination of ratios. The introduction of a net negative or positive charge on the surface of cholesterol-rich liposomes altered 6-carboxyfluorescein latency only slightly after intravenous injection (Table 2) : for up to 300 min, the latency range was about 92-97% (negative) and 103-108% (positive liposomes). Furthermore, clearance rates were again linear, although, as expected (Gregoriadis & Neerunjun, 1974; Juliano & Stamp, 1975; Tagesson et al., 1977) , positive and neutral liposomes were removed less rapidly than were negative ones (Fig. 3) .
Effect of the cholesterol content of small unilamellar liposomes on their stability in vitro Exposure of cholesterol-rich liposomes to whole mouse blood, plasma or serum (Fig. 4) resulted in a minor loss of latency. This, however, was significant in the case of serum (down to 86% of that in the preparation after 90min; Fig. 4c 88.9, 95.2 84.6, 88.4 of 6-carboxyfluorescein entrapped in cholesterolpoor liposomes was rapidly -decreased (to about 55% within 2min) in the presence of whole blood and reached a value of 13% after 90min (Fig. 4a) . As expected (see Fig. 2 ), latency of 6-carboxyfluorescein in cholesterol-free liposomes was reduced even more rapidly, with only 7% of its value being retained 2 min after mixing (Fig. 4a) . Latency for both types of liposomes in the presence of plasma (Fig. 4b) was initially (2 min) reduced to the same extent as in the presence of whole blood but, subsequently, its rate of decrease became more pronounced. Interestingly, serum (Fig. 4c) had a greater detrimental effect on the stability of cholesterol-free or cholesterol-poor liposomes than did whole blood or plasma. Fate of cholesterol-rich small unilamellar liposomes administered to mice by the intraperitoneal and intramuscular routes 6-Carboxyfluorescein in cholesterol-rich liposomes given by the intraperitoneal route (Fig. 5) entered the circulation to a considerable extent, reaching a peak (30% of the injected dose) in about 150min. Fig. 5 also shows that 6-carboxyfluorescein latency in the blood retained its initial value fully for at least 400 min, implying transport of intact liposomes from the peritoneal cavity into the blood circulation. This is further supported by the values of the liposomal lipid 14C and 6-carboxyfluorescein marker ratios, which remained similar to that (1.0) in the injected preparation for up to 450min (Table  1) . After intramuscular injection of the same liposomes, entrapped 6-carboxyfluorescein also entered the circulation, albeit at a much lower rate (legend to Fig. 5 ). However, its latency was diminished to 64% 360 min after injection (legend to Fig. 5 ).
Stability of cholesterol-rich small unilamellar liposomes after storage
Latency of 6-carboxyfluorescein in neutral and negatively charged cholesterol-rich liposomes stored at 40C for various periods of time (Table 3) presence ofwhole blood, plasma or serum Small unilamellar liposomes containing 6-carboxyfluorescein were mixed with mouse whole blood (a), plasma (b) or serum (c) and incubated at 37°C. 6-Carboxyfluorescein latency values in samples obtained at time intervals have been corrected for the loss of latency incurred during incubation of liposomes in the presence of 1% NaCl containing 0.63% sodium citrate and are the means from four to six experiments. They are expressed as percentages of the latencies in the respective liposomal preparations. These were 92.7 + 5.3 (four pireparations) for cholesterol-rich (0), 93.2 + 1.5 (three preparations) for cholesterol-poor (A) and 83.8 + 6.7 (three preparations) for cholesterol-free (-) liposomes. (Table 3) .
Discussion
When expressed in terms of 6-carboxyfluorescein retention, stability in vivo and in vitro of small unilamellar neutral liposomes is dependent on their cholesterol content. Cholesterol-rich liposomes, for instance, remain stable in the blood of intravenously injected animals ( Fig. 2 ) and in vitro in the presence of whole blood, plasma and, to a somewhat lesser extent, serum (Fig. 4) . This is supported by the almost total retention of 6-carboxyfluorescein latency under all conditions mentioned (Figs. 2 and 4) and, for the work done in vivo, by the pattern of 6-carboxyfluorescein clearance (Fig. 1 ) and the maintenance of the lipid/water-phase marker ratios at approximately their initial level (1.0) in the preparations before injection (Table 1) . The latter finding, indicating similar rates of elimination of the two labels from the blood (presumably as intact liposomes), rules out the possibility of significant leakage of 6-carboxyfluorescein and its subsequent rapid clearance. The stability of cholesterol-rich liposomes in vivo is also maintained when their net surface charge is negative or positive (Fig. 3 and Table  2 ). It would thus appear that interaction of liposomes with plasma proteins believed to occur in vitro (Black & Gregoriadis, 1976; Tyrrell et al., 1977; Scherphof et al., 1978) and in vivo (Krupp et al., 1976) results show beyond reasonable doubt that such liposomes survive in the peritoneal cavity to cross membranes and enter the circulation intact (Fig. 5) .
On the other hand, reduction in the liposomal cholesterol content leads to a very rapid (at most within 2min) decrease of 6-carboxyfluorescein latency in the blood of injected animals ( Fig. 2) and also in vitro in the presence of whole blood, plasma or serum (Fig. 4) . Indeed, the loss of 6-carboxyfluorescein latency for cholesterol-free liposomes is so rapid (Fig. 4) that, in vivo, the very rapid clearance of the freed dye ( Fig. 1 ) results in artificially high latency values for the 6-carboxyfluorescein that is still entrapped (Fig. 2) . The mechanism by which cholesterol controls liposomal stability within a biological milieu may be related to the finding that, upon contact with plasma, liposomes with little or no cholesterol lose some of their phospholipid to high-density lipoproteins (Krupp et al., 1976; Scherphof et al., 1978) . According to Scherphof et al. (1978) , this is associated with the liberation of previously entrapped agents. It is conceivable that excess sterol, by restricting the mobility of phospholipid (Ladbrooke et al., 1968; Demel & de Kruyff, 1976) , prevents the latter's subsequent loss to lipoproteins. Such an effect, expected to be proportional to the amount of cholesterol present, would thus explain the cholesterol-contentdependent latency that 6-carboxyfluorescein attains in vivo or in vitro (Figs. 2 and 4) .
The presence of blood cells, presumably erythrocytes, reduces the rate of loss of 6-carboxyfluorescein latency seen upon mixing of cholesterol-free or cholesterol-poor liposomes with plasma or serum (Fig. 4) . Two possible explanations can account for this finding: (a) erythrocytes are known to interact with lipoproteins in terms of phospholipid movement (Ladbrooke et al., 1968; Bruckdorfer & Graham, 1976; Demel & de Kruyff, 1976) , and it may be that such movement takes precedence over a similar one between liposomes and lipoproteins; (b) erythrocytes donate cholesterol to liposomes (Bruckdorfer et al., 1968) , and, if this takes place rapidly enough under the conditions described here, cholesterol-free and cholesterol-poor liposomes would be enriched in cholesterol and so less vulnerable to destabilization. It is of interest that loss of 6-carboxyfluorescein latency for cholesterol-poor or cholesterol-free liposomes in the presence of serum (Fig. 4c) is also reduced when this is replaced by blood plasma (Fig.  4b ), although to a significantly lesser extent than that observed with whole blood (Fig. 4a) . Plasma and serum differ by the absence of fibrinogen and some depletion of clotting factors in the latter. We are unable to explain at present how these differences contribute to the small but significant delay in the destabilization of such liposomes by plasma.
Regardless of the mechanism by which cholesterol and erythrocytes (and to some extent plasma) promote stability of liposomes, our data suggest that it may be possible to control drug release from liposomes. Such control is of particular relevance to chemotherapy, since in many instances it is desirable to transport entrapped drugs to target cells quantitatively, whereas in others a slow release is preferable Kimelberg & Mayhew, 1978) . From the practical point of view it is encouraging that the stability of cholesterol-rich small unilamellar liposomes observed after extended (at least 53 days) storage is also maintained in the intravascular space of injected animals (Table 3) .
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